ABN-Cognitive SIG Meeting

Event Notes:

• 10:00 Welcome and Introduction Dr Akram Hosseini, Nottingham University Hospitals NHS Trust
• 10:15 – 12:30 Session 1: Alzheimer’s Disease Modifying Therapy and Future Directions
• Current Status of Amyloid therapy and Implementation in the UK Prof Cath Mummery, UCL
• Insights from Clinical Trials and U.S. Experiences with Emerging Therapies Prof Sudha Seshadri University of South Texas
• Non-Amyloid therapies for Alzheimer’s disease Dr Damian Crowther, TRIMTECH Therapeutics
• Data Blitz 11:45 – 12:00
• Panel Discussions and Q&A 12:00 – 12:30
• 12:30 – 13:30 Lunch
• 13:30 – 15:45
• Session 2: Therapy Inclusion, and Monitoring Amyloid Therapy Side Effects
• Amyloid-Related Imaging Abnormalities Dr Jagrit Shah Nottingham University Hospitals NHS Trust
• Blood biomarkers and clinical use Prof Vanessa Raymont, University of Oxford
• The Role and Feasibility of Amyloid PET imaging in clinical practice Prof Paul Edison, Imperial College London
• Data Blitz 15:00 – 15:15
• Panel discussions and Q&A 15:15 – 15:45
• 15:45 – 16:00 Tea Break
• 16:00-17:00: Expert Panel Discussion: Pathways for Disease-Modifying Therapies and Monitoring for UK Memory Clinics
• 17:00 Close